Australian Pharmacist

Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.

The future of pharmacy is bright, engaged and passionate, the search for the latest PSA MIMS Intern Pharmacist of the Year has revealed. Judges were...

PSA’s 2025 Early Career Pharmacist of the Year, Dr Kate Wang is shaping pharmacy education and aged care policy.

Jennifer Cooke, the Editor of Australian Pharmacist, talks with Katherine Higgins, a pharmacist in South Perth, Western Australia.

A study has found a pharmacy-driven protocol using nasal swabs to assess methicillin‑resistant Staphylococcus aureus (MRSA) in pneumonia cases holds promise for reducing unnecessary...

As cold and flu season reaches fever pitch, the demand for complementary medicines to help prevent and manage colds and influenza is increasing. A...